Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Market Cap	2.83B
Revenue (ttm)	595.03M
Net Income (ttm)	85.35M
Shares Out	44.93M
EPS (ttm)	1.88
PE Ratio	33.46
Forward PE	n/a
Dividend	1.75 (2.76%)
Ex-Dividend Date	Jun 26, 2025

Volume	23,548
Average Volume	28,057
Open	63.00
Previous Close	62.90
Day's Range	62.10 - 63.00
52-Week Range	56.60 - 88.30
Beta	-0.17
RSI	59.30
Earnings Date	Aug 11, 2025

About Everi Holdings

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was founded...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 171
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2024, TPEX:4747's revenue was 611.42 million, an increase of 0.78% compared to the previous year's 606.71 million. Earnings were 84.12 million, an increase of 5.55%.